Reply to Francesco Montorsi, Alessandro Larcher, and Umberto Capitanio's Letter to the Editor re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. 2019 Jun 24. pii: S2405-4569(19)30157-9. https://doi.org/10.1016/j.euf.2019.06.002. [Epub ahead of print]

Affiliations

¹ Department of Radiation Oncology, London Regional Cancer Program, London, Ontario, Canada.
² Department of Radiation Oncology, Sunnybrook Health Sciences Centre and the University of Toronto, Toronto, Ontario, Canada.
³ Department of Radiation Oncology, Penn State Cancer Institute, Hershey, PA, USA.
⁴ Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁵ University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA.
⁶ Beth Israel Deaconess Medical Center, Boston, MA, USA.
⁷ Geisinger Health, Danville, PA, USA.
⁸ Department of Radiation Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada.
⁹ Department of Radiation Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
¹⁰ Department of Radiology, University of Yamanashi, Yamanashi, Japan.
¹¹ Department of Radiation Oncology, Houston Methodist Hospital, Cancer Center and Research Institute, Houston, TX, USA.
¹² University of Munich Hospitals, Munich, Germany.
¹³ Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA.
¹⁴ Division of Radiation Oncology & Cancer Imaging, Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, Australia. Electronic address: shankar.siva@petermac.org.

Comment

Rohann J M Correa et al. Eur Urol Focus. 2021 Mar.

. 2021 Mar;7(2):404-405.

doi: 10.1016/j.euf.2019.10.004. Epub 2019 Nov 1.

¹ Department of Radiation Oncology, London Regional Cancer Program, London, Ontario, Canada.
² Department of Radiation Oncology, Sunnybrook Health Sciences Centre and the University of Toronto, Toronto, Ontario, Canada.
³ Department of Radiation Oncology, Penn State Cancer Institute, Hershey, PA, USA.
⁴ Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁵ University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA.
⁶ Beth Israel Deaconess Medical Center, Boston, MA, USA.
⁷ Geisinger Health, Danville, PA, USA.
⁸ Department of Radiation Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada.
⁹ Department of Radiation Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
¹⁰ Department of Radiology, University of Yamanashi, Yamanashi, Japan.
¹¹ Department of Radiation Oncology, Houston Methodist Hospital, Cancer Center and Research Institute, Houston, TX, USA.
¹² University of Munich Hospitals, Munich, Germany.
¹³ Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA.
¹⁴ Division of Radiation Oncology & Cancer Imaging, Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, Australia. Electronic address: shankar.siva@petermac.org.

No abstract available

Comment on

The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Correa RJM, Louie AV, Zaorsky NG, Lehrer EJ, Ellis R, Ponsky L, Kaplan I, Mahadevan A, Chu W, Swaminath A, Hannan R, Onishi H, Teh BS, Muacevic A, Lo SS, Staehler M, Siva S. Correa RJM, et al. Eur Urol Focus. 2019 Nov;5(6):958-969. doi: 10.1016/j.euf.2019.06.002. Epub 2019 Jun 24. Eur Urol Focus. 2019. PMID: 31248849
Re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2019.06.002.
Montorsi F, Larcher A, Capitanio U. Montorsi F, et al. Eur Urol Focus. 2021 Mar;7(2):406. doi: 10.1016/j.euf.2019.08.018. Epub 2019 Sep 26. Eur Urol Focus. 2021. PMID: 31564640 No abstract available.